,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-02-28 05:25:00,"Investors who are stashing away shares in Royal Dutch Shell plc (NYSE: RDS-B) , Procter & Gamble (NYSE: PG) , and Celgene Corp. (NASDAQ: CELG) in retirement accounts are making the right choice, according to these top Motley Fool contributors.",0.19867043197155,0.0296701118350029,0.7716594338417053,neutral,0.16900032758712769
1,2017-02-28 05:25:00,"All three of these companies have intriguing opportunities that could send shares higher over the long haul, and that might make them valuable additions to your portfolio, too.",0.8325855731964111,0.013765621930360794,0.1536487489938736,positive,0.8188199400901794
2,2017-02-28 05:25:00,Reuben Gregg Brewer (Royal Dutch Shell plc): The company made a big and expensive natural gas bet during the oil downturn that's been a major headwind for the stock.,0.03342384845018387,0.9355651140213013,0.031011013314127922,negative,-0.902141273021698
3,2017-02-28 05:25:00,"The oil giant's more than $50 billion acquisition of BG Group pushed debt up 50% year over year in the fourth quarter of 2016, to a massive $83 billion.",0.9395907521247864,0.022480938583612442,0.03792833909392357,positive,0.9171097874641418
4,2017-02-28 05:25:00,"That's roughly 30% of Shell's capital structure, which is high relative to peers like ExxonMobil and Chevron .",0.39269113540649414,0.009862194769084454,0.597446620464325,neutral,0.382828950881958
5,2017-02-28 05:25:00,But here's the thing: The company's debt load was even higher during the year.,0.9009464383125305,0.02299126237630844,0.07606232166290283,positive,0.8779551982879639
6,2017-02-28 05:25:00,And that's the important takeaway.,0.18296606838703156,0.01683717593550682,0.8001967072486877,neutral,0.16612888872623444
7,2017-02-28 05:25:00,Shell is starting to dig itself out of its debt hole by selling non-core assets.,0.07715749740600586,0.10603449493646622,0.8168079853057861,neutral,-0.028876997530460358
8,2017-02-28 05:25:00,"As it travels down this path, meanwhile, it's going to rebalance its business with an increasing focus on natural gas -- an area in which it's already a dominant player.",0.8166109919548035,0.012610899284482002,0.17077811062335968,positive,0.8040000796318054
9,2017-02-28 05:25:00,"Natural gas is expected to grow in importance, taking share from dirtier energy options like oil and coal.",0.902079701423645,0.026983384042978287,0.07093685865402222,positive,0.875096321105957
10,2017-02-28 05:25:00,RDS.B Debt to Equity Ratio (Quarterly) data by YCharts .,0.02643417939543724,0.045371897518634796,0.9281938672065735,neutral,-0.018937718123197556
11,2017-02-28 05:25:00,"Royal Dutch Shell, a company that's been around for well over 100 years, looks like it's starting to get its financial house in order after an expensive, but potentially transformational, acquisition.",0.8778142333030701,0.01733221486210823,0.10485348105430603,positive,0.8604820370674133
12,2017-02-28 05:25:00,"As it strengthens its balance sheet, the security of its dividend improves, too.",0.946560263633728,0.01599707081913948,0.03744269907474518,positive,0.93056321144104
13,2017-02-28 05:25:00,This is why now could be the right time to jump on Shell's 6.8% yield.,0.6428428292274475,0.027763262391090393,0.3293939530849457,positive,0.6150795817375183
14,2017-02-28 05:25:00,"For comparison, Chevron yields around 3.9% and Exxon 3.7%.",0.04084964469075203,0.05457426607608795,0.9045760631561279,neutral,-0.013724621385335922
15,2017-02-28 05:25:00,"Shell's higher yield could be a nice boost for your retirement as you wait for the rest of the market to realize that the oil giant is, indeed, resolving the debt issue.",0.5765323638916016,0.0241832435131073,0.39928436279296875,positive,0.5523490905761719
16,2017-02-28 05:25:00,"A new look at an old business

Demitri Kalogeropoulos(Procter & Gamble): Procter & Gamble shares recently hit a two-year high to make the consumer goods giant one of the best-performing stocks on the Dow in 2017.",0.9385101199150085,0.033725518733263016,0.027764346450567245,positive,0.904784619808197
17,2017-02-28 05:25:00,"The latest bump came after Wall Street learned that an activist investor had accumulated a big position in the company and may push management to make a few profit-boosting, shareholder-friendly moves.",0.7968736290931702,0.10179555416107178,0.10133082419633865,positive,0.6950780749320984
18,2017-02-28 05:25:00,But the dividend giant is already doing much of what any billionaire activist investor might recommend.,0.20653851330280304,0.014569249004125595,0.7788921594619751,neutral,0.19196926057338715
19,2017-02-28 05:25:00,"It just finished its biggest portfolio reboot in its history, which knocked down the number of brands from 166 to just 65.",0.0489029623568058,0.9065000414848328,0.044597093015909195,negative,-0.8575970530509949
20,2017-02-28 05:25:00,"Costs are plummeting, and executives plan to slice a further $10 billion out of expenses over the next few years.",0.314113974571228,0.5900899767875671,0.09579601883888245,negative,-0.2759760022163391
21,2017-02-28 05:25:00,The company's capital return program is also one of the most generous on the market -- $22 billion this year alone .,0.7553411722183228,0.013325182721018791,0.2313336580991745,positive,0.7420160174369812
22,2017-02-28 05:25:00,The bold strategic moves appear to be working.,0.7717218399047852,0.013242105022072792,0.21503600478172302,positive,0.7584797143936157
23,2017-02-28 05:25:00,"Profitability is up, sales growth is accelerating, and P&G is poised to end a two-year earnings slump by boosting profits by around 5% this year.",0.9543068408966064,0.01989963836967945,0.025793591514229774,positive,0.9344071745872498
24,2017-02-28 05:25:00,"Its market-share slide, meanwhile, could be ending too: Management just raised its full-year organic sales growth target to 2.5% from 2%.",0.9072708487510681,0.05673731490969658,0.03599189966917038,positive,0.8505335450172424
25,2017-02-28 05:25:00,"Thanks to its leading position across consumer staples like razors, diapers, and paper towels, P&G has long been a favorite of investors seeking steadily growing returns at unusually low risks.",0.8674149513244629,0.014839797280728817,0.11774522066116333,positive,0.8525751829147339
26,2017-02-28 05:25:00,"They moved away from the stock over the last few years as profits declined, but are rushing back in now that its business prospects are improving.",0.14537271857261658,0.3310973644256592,0.5235298871994019,neutral,-0.1857246458530426
27,2017-02-28 05:25:00,"Todd Campbell(Celgene) : A larger, longer-living America is one of the biggest trends, and many investors interested in profiting long-term from aging baby boomers are already stashing Celgene away in portfolios.",0.06573188304901123,0.0471322163939476,0.887135922908783,neutral,0.01859966665506363
28,2017-02-28 05:25:00,Celgene is the market-share-leading maker of drugs used to treat multiple myeloma (Revlimid and Pomalyst).,0.7627910375595093,0.011923140846192837,0.22528578341007233,positive,0.7508679032325745
29,2017-02-28 05:25:00,It also markets top-selling blockbuster drugs used to treat pancreatic cancer (Abraxane) and psoriasis (Otezla).,0.37037378549575806,0.008883243426680565,0.6207429766654968,neutral,0.36149054765701294
30,2017-02-28 05:25:00,"Soon, it may add yet another best-selling drug to its lineup that treats multiple sclerosis, a big-time indication valued at $19 billion annually.",0.8635698556900024,0.015125300735235214,0.12130481749773026,positive,0.8484445810317993
31,2017-02-28 05:25:00,"Management is one of only a few out there that offers up long-term forecasts, and its forecast for the future is downright ambitious.",0.07214149087667465,0.008532147854566574,0.9193263053894043,neutral,0.06360934674739838
32,2017-02-28 05:25:00,The company hopes to grow from about $13 billion in sales this year to $21 billion in sales in 2020.,0.8391836881637573,0.011982162483036518,0.1488340198993683,positive,0.8272015452384949
33,2017-02-28 05:25:00,"If it can hit that target, then it thinks earnings per share (EPS) could exceed $13.",0.8691718578338623,0.01768137887120247,0.11314670741558075,positive,0.8514904975891113
34,2017-02-28 05:25:00,"If so, then owning shares today could prove to be very profit-friendly for long-term investors.",0.9022889137268066,0.01541049126535654,0.08230061084032059,positive,0.8868784308433533
35,2017-02-28 05:25:00,"Couple that forecast with a rock-solid balance sheet that includes $6.1 billion in cash and equivalents and another $1.8 billion in short-term investments, and you have a well-heeled company with a proven track record of success, and the potential for significant growth.",0.8534409999847412,0.013037108816206455,0.13352183997631073,positive,0.8404039144515991
36,2017-02-28 05:25:00,That's a pretty compelling story.,0.18455097079277039,0.009992193430662155,0.8054568767547607,neutral,0.17455877363681793
37,2017-02-28 05:25:00,"Obviously, no one knows if Celgene can continue to deliver breakthroughs that allow it to stay ahead of its competitors.",0.8908655047416687,0.02177427150309086,0.0873601883649826,positive,0.8690912127494812
38,2017-02-28 05:25:00,"However, if the past is any indication, I'm not about to bet against it -- especially since 76 million baby boomers are going to be demanding increasingly more treatment over the next couple of decades.",0.08277834951877594,0.07855714112520218,0.8386645317077637,neutral,0.004221208393573761
39,2017-02-28 05:25:00,"10 stocks we like better than Celgene

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.13719406723976135,0.028193676844239235,0.8346123099327087,neutral,0.10900039225816727
40,2017-02-28 05:25:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
41,2017-02-28 05:25:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Celgene wasn't one of them!",0.19925305247306824,0.013416319154202938,0.7873306274414062,neutral,0.18583673238754272
42,2017-02-28 05:25:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
43,2017-02-28 05:25:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
44,2017-02-28 05:25:00,Demitrios Kalogeropoulos has no position in any stocks mentioned.Reuben Brewer owns shares of ExxonMobil.,0.010850946418941021,0.017625980079174042,0.9715230464935303,neutral,-0.006775033660233021
45,2017-02-28 05:25:00,Todd Campbell owns shares of Celgene.His clients may have positions in the companies mentioned.The Motley Fool owns shares of and recommends Celgene.,0.01804531179368496,0.013098728843033314,0.9688559770584106,neutral,0.004946582950651646
46,2017-02-28 05:25:00,The Motley Fool owns shares of ExxonMobil.,0.04248303920030594,0.03388557583093643,0.9236314296722412,neutral,0.008597463369369507
47,2017-02-28 05:25:00,The Motley Fool recommends Chevron.,0.044420864433050156,0.0472375713288784,0.9083415865898132,neutral,-0.002816706895828247
48,2017-02-28 05:25:00,The Motley Fool has a disclosure policy .,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
49,2017-02-28 05:25:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
